A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

NCT04171700 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
83
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to a change in development priorities.

Conditions

Interventions

Sponsor

pharmaand GmbH